Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001171843-25-002595
Filing Date
2025-04-29
Accepted
2025-04-29 15:59:49
Documents
18
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A xbit20241231_10ka.htm   iXBRL 10-K/A 362005
2 EXHIBIT 31.1 ex_808425.htm EX-31.1 3656
3 EXHIBIT 31.2 ex_808426.htm EX-31.2 3632
  Complete submission text file 0001171843-25-002595.txt   671385

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA xbit-20241231.xsd EX-101.SCH 5397
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbit-20241231_def.xml EX-101.DEF 16288
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20241231_lab.xml EX-101.LAB 35026
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20241231_pre.xml EX-101.PRE 20692
21 EXTRACTED XBRL INSTANCE DOCUMENT xbit20241231_10ka_htm.xml XML 11907
Mailing Address 5217 WINNEBAGO LANE AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37347 | Film No.: 25886912
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)